Core Laboratories
CLB
183 hedge funds and large institutions have $1.24B invested in Core Laboratories in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 24 closing their positions.
304% more call options, than puts
Call options by funds: $5.23M | Put options by funds: $1.29M
21% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 24
8% more capital invested
Capital invested by funds: $1.14B → $1.24B (+$96.3M)
1% more funds holding
Funds holding: 181 → 183 (+2)
9% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 57
3.75% less ownership
Funds ownership: 96.84% → 93.09% (-3.8%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
BlackRock
New York
|
+$28.6M |
| 2 |
FAM
Fred Alger Management
New York
|
+$28.3M |
| 3 |
Truist Financial
Charlotte,
North Carolina
|
+$14.9M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.78M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.51M |
Top Sellers
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$25M |
| 2 |
AC
AKO Capital
London,
United Kingdom
|
-$18.8M |
| 3 |
CPH
C Partners Holding
Zurich,
Switzerland
|
-$12.5M |
| 4 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
-$9.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.03M |
CLB Hedge Fund Activity: Q1 2021 in Review
183 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2021, worth a combined $1.24B — up 8.4% from $1.14B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new CLB positions and 24 closed out — a net gain of 5 holders — while 62 added to existing stakes and 57 trimmed.
The largest buyer was BlackRock, adding an estimated $28.6M. The largest seller was Ariel Investments, cutting an estimated $25M.
- 183 institutional investors held Core Laboratories (CLB) as of Q1 2021, up from 181 in Q4 2020.
- Funds reported $1.24B of Core Laboratories stock for Q1 2021, up 8.4% quarter-over-quarter.
- 29 funds opened new Core Laboratories positions in Q1 2021 and 24 closed out, a net change of +5 holders.
- The largest Core Laboratories buyer in Q1 2021 was BlackRock, an estimated $28.6M added.
- The largest Core Laboratories seller in Q1 2021 was Ariel Investments, an estimated $25M sold.
Based on aggregated 13F filings for Q1 2021.